Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization and Modulation of Functional Connectivity and Fear Extinction Abnormalities in Obsessive-Compulsive Disorder

NCT06834217 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT06834217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06834217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization and Modulation of Functional Connectivity and Fear Extinction Abnormalities in Obsessive-Compulsive Disorder
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Recruiting
Start date
September 12, 2025
Completion date
August 1, 2029
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obsessive compulsive disorder (ocd)